Skip to search formSkip to main contentSkip to account menu

Boron Delivery Agent

Known as: BNCT Agent, Boron Neutron Capture Therapy Agents, Boron Transport Agent 
Agents used in Boron Neutron Capture Therapy, a type of radiotherapy, as boron (boron-10) carriers.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A New Boron-10 Delivery Agent for Boron Neutron Capture Therapy: Fluorescent Boron-10 Embedded Nanodiamonds.
Boron neutron capture therapy is a powerful anti-cancer treatment, the success of which depends heavily on the boron delivery… 
2013
2013
Estimation of Boron-containing Rare Earth Oxides as Drugs for Boron Neutron Capture Therapy
SUMMARY In order to improve the efficiency of Boron Neutron Capture Therapy (BNCT), we synthesized the oxides of rare earth… 
2013
2013
Application of a Novel Boron Carrier : Kojic Acid-Appended Carborane / Hydroxypropyl-β-Cyclodextrin Complex for Boron Neutron Capture Therapy
SUMMARY In order to construct a novel boron delivery agent for Boron Neutron Capture Therapy (BNCT) toward melanoma, we evaluated… 
2012
2012
Preparation of dopamine-modified boron nanoparticles
We developed a method to obtain water-dispersible boron nanoparticles (BNPs) as a potential boron delivery agent for cancer… 
2011
2011
Synthesis and Biological Data of ortho-Carborane Analogs from 4-Aminobenzoic Acid and 4-Hydroxybenzoic Acid as a Potential Boron Neutron Capture Therapy Agent
Department of Chemistry, Faculty of Science, Gakushuin University, Tokyo 171-8588, JapanReceived October 8, 2010, Accepted April… 
Review
2008
Review
2008
Molecular TargetingandTreatmentof Composite EGFRand EGFRvIII-Positive Gliomas Using BoronatedMonoclonal Antibodies
Purpose:The purpose of the present study was to evaluate the anti ^ epidermal growth factor receptor (EGFR) monoclonal antibody… 
Highly Cited
2004
Highly Cited
2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
1999
1999
Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma.
BACKGROUND We prepared boron containing lipiodol (B-lipiodol), elucidated the retention of B-lipiodol in hepatoma cells and… 
1996
1996
BNCT of Malignant Melanoma-Radiobiological Analysis and Data Comparison with Conventional Radiotherapy
Research on selective melanoma neutron capture therapy was initiated by Y. Mishima and his associates, consisting of physicists… 
1996
1996
The preparation of a fluorine-18 labeled orthocarborane for use in the PET imaging of new boron neutron capture therapy agents
This investigation was undertaken to develop a method to radiofluorinate carboranes which are currently being utilized as boron… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)